Journal of the American Academy of Dermatology
Volume 31, Issue 5, Part 1, November 1994, Pages 819-822
Proceedings of the Second International Symposium on Cutaneous T-cell Lymphoma: Chicago, Illinois, Oct. 13–17, 1993
References (10)
- et al.
Long-term efficacy, curative potential, and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T cell lymphoma
J Am Acad Dermatol
(1989) - et al.
Topical carmustine (BCNU) for cutaneous T cell lymphoma: a 15-year experience in 143 patients
J Am Acad Dermatol
(1990) - et al.
Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy
J Am Acad Dermatol
(1992) - et al.
Report of the Committee on Staging and Classification of cutaneous T-cell lymphomas
Cancer Treat Rep
(1979) - et al.
Mycosis fungoides: survival, prognostic features, response to therapy, and autopsy findings
Medicine
(1972)
There are more references available in the full text version of this article.
Cited by (16)
Defining the mimics and clinico-histological diagnosis criteria for mycosis fungoides to minimize misdiagnosis
2017, International Journal of Women's DermatologyCitation Excerpt :In addition, topical steroid therapy and systemic immunosuppressant medications may influence the findings up to 2 to 4 weeks (Nickoloff 1988; Pimpinelli et al., 2005). These difficulties are highlighted by the false-negative and false-positive reporting rates, which can be as high as 40% (Herrmann et al., 1994), and the low concordance and reproducibility rates (Guitart et al., 2001; Olerud et al., 1992; Pimpinelli et al., 2005). Clinically, MF was mimicked by other biopsy-proven inflammatory diseases such as eczema, psoriasis, nonspecific dermatitis, lichen, lupus, pseudolymphoma, parapsoriasis, and toxidermia.
Practical evaluation and management of cutaneous lymphoma
2002, Journal of the American Academy of DermatologyCutaneous T-cell lymphoma: Refinement in the application of controversial histologic criteria
1999, Dermatologic ClinicsDurable loss of a malignant T-cell clone in a stage IV cutaneous T-cell lymphoma patient treated with high-dose interferon and photopheresis
1999, Journal of the American Academy of DermatologyCutaneous pseudolymphomas
1998, Journal of the American Academy of DermatologyLong-term follow-up of patients with cutaneous T-cell lymphoma treated with extracorporeal photochemotherapy
1996, Journal of the American Academy of Dermatology
Copyright © 1994 Published by Mosby, Inc. All rights reserved.